New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

11

Covid-19 vaccine confidence grows as side effect worries fade

Confidence in Covid-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on March 5.

12

Phase III Trial Shows Lilly’s Tirzepatide is Superior to Rival in Type 2 Diabetes

Eli Lilly’s Phase III SURPASS-2 clinical trial shows that treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist, is associated with superior reductions in body weight and blood sugar compared with injectable semaglutide in adults with type 2 diabetes.

13

Alabama extends Covid mask mandate for a month amid debate between Texas, Biden

Alabama’s governor on March 4 extended for another month an order mandating residents to wear face masks to protect against Covid-19, breaking with Mississippi and Texas as the issue again becomes the focus of political debate.

16

KemPharm Snags Approval for ADHD Prodrug

One year after submitting a New Drug Application for Azstarys, the U.S. Food and Drug Administration approved KemPharm’s novel ADHD drug for use in patients 6 years and older.